Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate
{{output}}
Elevated serum phosphate levels as a consequence of chronic kidney disease (CKD) contribute to the increased cardiovascular risk observed in dialysis patients. Protein restriction and dialysis fail to adequately prevent hyperphosphatemia, and in general treatm... ...